Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 269 participants.
Also called NCT03565913
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 269 participants
- Registry
-
NCT03565913
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03565913. Randomized; quadruple masking; primary purpose treatment. Start 2017-01-22 (actual); primary completion 2026-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V
- Condition
- CKD Stage 5
- Intervention (Drug)
- EffCaMgCit
- Intervention (Other)
- CaAcS
- Lead sponsor
- University of Texas Southwestern Medical Center
Record details
- Record id
cardio:ct-nct03565913- Content hash
d9f094cf29e218a2bc276496f9fcf1927a89de93fb19fb85ec99e0264c318570